| Company | Sales | Gross M. | SGA % Sales | R&D % Sales | Trading M. | Tax Rate | Net Income | EPS |
| | | | | | | | |
| Vertex | 19.4% | 0.3% | -11.2% | -14.7% | 20.8% | 3.2% | 29.6% | 28.5% |
| Bristol | 15.8% | 2.0% | -5.8% | -0.9% | 8.1% | 0.6% | 23.0% | 15.8% |
| AbbVie | 13.1% | -0.3% | 0.1% | -6.3% | 0.3% | 13.1% | 11.6% | 8.0% |
| Mylan | 13.0% | 4.5% | 1.1% | -3.2% | 9.9% | -1.1% | 25.9% | 2.6% |
| Exelixis | 13.0% | -0.1% | -5.1% | -6.0% | 8.8% | 2.8% | 19.4% | 18.5% |
| Astra | 10.5% | 0.3% | -5.2% | -5.3% | 11.6% | -1.1% | 20.5% | 20.3% |
| Alexion | 9.0% | -0.2% | -2.0% | 4.7% | -0.9% | 4.2% | 7.8% | 8.4% |
| Novo | 7.4% | -0.3% | -1.4% | 0.3% | 0.1% | 0.5% | 9.4% | 11.5% |
| ONO | 7.3% | -0.2% | -3.4% | -2.3% | 4.6% | -0.1% | 12.1% | 12.2% |
| Merck KG | 6.2% | -0.4% | -1.7% | -2.1% | 8.6% | 2.4% | 9.9% | 10.0% |
| Eisai | 6.1% | 0.2% | 0.4% | -2.6% | 5.3% | 2.1% | 10.9% | 10.9% |
| Regeneron | 5.4% | 0.0% | -0.1% | -5.2% | 2.8% | 3.5% | 6.2% | 5.5% |
| Lundbeck | 5.1% | 0.6% | -1.0% | 0.7% | 4.9% | -1.3% | 5.7% | 5.0% |
| Lilly | 5.0% | 0.2% | -3.1% | -2.7% | 4.4% | 4.3% | 8.8% | 10.6% |
| Amgen | 4.4% | 0.0% | -0.4% | -0.1% | 0.6% | 0.3% | 5.2% | 7.7% |
| Astellas | 4.3% | 0.6% | -0.8% | -1.8% | 3.7% | -1.3% | 9.1% | 9.9% |
| JnJ | 4.3% | 0.3% | -1.7% | -1.3% | 2.9% | -1.0% | 5.7% | 6.3% |
| Glaxo | 4.2% | 0.2% | -1.2% | 0.4% | 1.8% | 2.5% | 4.9% | 4.4% |
| Merck | 4.1% | 0.3% | -2.6% | -1.2% | 2.4% | 1.1% | 6.7% | 8.2% |
| Chugai | 4.1% | 1.2% | 1.3% | 0.5% | 2.6% | 1.7% | 7.4% | 7.8% |
| Otsuka | 4.1% | 0.4% | -0.1% | -0.4% | 3.9% | 0.8% | 8.4% | 8.5% |
| Daiichi | 3.7% | 0.6% | -0.2% | -1.4% | 5.5% | -0.9% | 10.0% | 10.0% |
| Novartis | 3.4% | 0.3% | -0.9% | -0.3% | 2.7% | 0.2% | 6.4% | 7.2% |
| Roche | 3.2% | 0.3% | -0.9% | -0.8% | 1.4% | 0.5% | 5.0% | 5.1% |
| Sanofi | 2.8% | 0.2% | -1.8% | -1.6% | 3.2% | -0.3% | 4.3% | 4.6% |
| Bayer | 2.8% | 2.0% | -0.5% | -0.6% | 14.1% | 5.0% | 10.2% | 10.4% |
| Shionogi | 2.3% | -0.4% | -0.8% | 2.5% | -1.3% | 0.2% | 2.0% | 2.0% |
| Takeda | 1.6% | 2.7% | -3.4% | -3.0% | | 60.9% | | |
| UCB | 0.8% | 0.4% | -0.6% | -1.2% | 3.6% | -0.2% | 6.0% | 6.1% |
| Gilead | 0.4% | 0.0% | 0.4% | 1.4% | -0.4% | 0.6% | -0.2% | 1.4% |
| Teva | 0.3% | 1.0% | -0.1% | -0.9% | 2.0% | -0.5% | 4.0% | 3.7% |
| Biogen | 0.0% | -0.1% | 2.1% | 1.0% | -2.2% | 2.7% | -2.3% | 0.6% |
| Pfizer | -1.7% | 0.3% | -2.3% | 2.8% | 1.0% | 0.1% | 1.0% | 2.2% |
| US Biotechs | 13.0% | -0.1% | -5.1% | -6.0% | 8.8% | 2.8% | 19.4% | 18.5% |
| EU Major | 4.2% | 0.6% | -1.4% | -1.1% | 3.9% | 0.9% | 7.5% | 7.9% |
| Other EU | 5.0% | -0.2% | -1.3% | -2.1% | 6.5% | 1.9% | 8.6% | 7.6% |
| US Major | 5.8% | 0.4% | -2.8% | -1.1% | 3.0% | 1.4% | 8.3% | 8.7% |
| US Big Biotech | 3.8% | 0.0% | -0.5% | -1.1% | 0.4% | 1.5% | 4.1% | 5.9% |
| Other US | 6.0% | 3.1% | 0.6% | -2.7% | 7.2% | -0.6% | 15.6% | 3.0% |
| Japanese | 3.4% | 1.2% | -1.2% | -1.5% | 16.2% | -4.8% | 25.9% | 13.5% |